Mounjaro beat Wegovy for weight loss in a head-to-head trial, but its edge over high-dose Wegovy is less clear; Novo Nordisk and Eli Lilly also presented competing data on heart protection and weight-loss pills at Europe’s diabetes conference | Read More in ynet – Culture